Comparison 7. Ciprofloxacin (500 mg twice daily) and metronidazole (500 mg twice daily) and budesonide (9 mg daily) versus placebo and budesonide (9 mg daily).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Failure to enter clinical remission at week 8	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2 Adverse events	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3 Serious adverse events	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
4 Withdrawal due to adverse events	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected